Carbidopa: Medgend

CARBIDOPA [Carbidopa^{C₁₀H₁₄N₂O₄H₂O}]

RX

-

25mg (oral tablet)

Alvogen Malta^{Jan 8, 2016}
Amerigen Pharms Ltd^{Mar 10, 2014}
Edenbridge Pharms^{Feb 17, 2016}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CARBIDOPA AND LEVODOPA [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Levodopa^{C₉H₁₁NO₄}]

RX

-

10mg : 100mg (oral tablet)

25mg : 100mg (oral tablet, extended release)

25mg : 250mg (oral tablet)

50mg : 200mg (oral tablet, extended release)

Actavis Elizabeth^{Sep 3, 1993}
Apotex Inc^{Jun 2, 2008}
Mayne Pharma^{Aug 28, 1992}
Mylan^{Sep 18, 2008}
Sun Pharm Inds^{Oct 28, 2008}
Sun Pharma Global^{Jul 31, 2009}
Accord Hlthcare^{Feb 8, 2013}
Impax Labs^{May 14, 2004}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CARBIDOPA, LEVODOPA AND ENTACAPONE [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Entacapone^{C₁₄H₁₅N₃O₅} : Levodopa^{C₉H₁₁NO₄}]

RX

-

12.5mg : 200mg : 50mg (oral tablet)

18.75mg : 200mg : 75mg (oral tablet)

25mg : 200mg : 100mg (oral tablet)

31.25mg : 200mg : 125mg (oral tablet)

37.5mg : 200mg : 150mg (oral tablet)

50mg : 200mg : 200mg (oral tablet)

Wockhardt Ltd^{Nov 20, 2012}
Sun Pharma Global^{May 10, 2012}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

DUOPA [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Levodopa^{C₉H₁₁NO₄}]

RX

-

4.63mg/ml : 20mg/ml (enteral suspension)

Abbvie Inc^{Jan 9, 2015}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

LODOSYN [Carbidopa^{C₁₀H₁₄N₂O₄H₂O}]

RX

-

25mg (oral tablet)

Aton^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

RYTARY [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Levodopa^{C₉H₁₁NO₄}]

RX

-

23.75mg : 95mg (oral capsule, extended release)

36.25mg : 145mg (oral capsule, extended release)

48.75mg : 195mg (oral capsule, extended release)

61.25mg : 245mg (oral capsule, extended release)

Impax Labs Inc^{Jan 7, 2015}

Method of providing a therapeutically effective and stable median blood plasma level of levodopa.
Treatment of parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Treatment of parkinson's disease.
Treatment of parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Treatment of post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.
Treatment of post-encephalitic parkinsonism.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SINEMET [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Levodopa^{C₉H₁₁NO₄}]

RX

-

10mg : 100mg (oral tablet)

25mg : 100mg (oral tablet)

25mg : 250mg (oral tablet)

Merck Sharp Dohme^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

SINEMET CR [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Levodopa^{C₉H₁₁NO₄}]

RX

-

25mg : 100mg (oral tablet, extended release)

50mg : 200mg (oral tablet, extended release)

Merck Sharp Dohme^{Dec 24, 1992}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

STALEVO 100 [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Entacapone^{C₁₄H₁₅N₃O₅} : Levodopa^{C₉H₁₁NO₄}]

RX

-

25mg : 200mg : 100mg (oral tablet)

Orion Pharma^{Jun 11, 2003}

Treatment of parkinson's disease.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

STALEVO 125 [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Entacapone^{C₁₄H₁₅N₃O₅} : Levodopa^{C₉H₁₁NO₄}]

RX

-

31.25mg : 200mg : 125mg (oral tablet)

Orion Pharma^{Aug 29, 2008}

Treatment of parkinson's disease.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

STALEVO 150 [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Entacapone^{C₁₄H₁₅N₃O₅} : Levodopa^{C₉H₁₁NO₄}]

RX

-

37.5mg : 200mg : 150mg (oral tablet)

Orion Pharma^{Jun 11, 2003}

Treatment of parkinson's disease.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

STALEVO 200 [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Entacapone^{C₁₄H₁₅N₃O₅} : Levodopa^{C₉H₁₁NO₄}]

RX

-

50mg : 200mg : 200mg (oral tablet)

Orion Pharma^{Aug 2, 2007}

Treatment of parkinson's disease.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

STALEVO 50 [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Entacapone^{C₁₄H₁₅N₃O₅} : Levodopa^{C₉H₁₁NO₄}]

RX

-

12.5mg : 200mg : 50mg (oral tablet)

Orion Pharma^{Jun 11, 2003}

Treatment of parkinson's disease.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

STALEVO 75 [Carbidopa^{C₁₀H₁₄N₂O₄H₂O} : Entacapone^{C₁₄H₁₅N₃O₅} : Levodopa^{C₉H₁₁NO₄}]

RX

-

18.75mg : 200mg : 75mg (oral tablet)

Orion Pharma^{Aug 29, 2008}

Treatment of parkinson's disease.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

XADAGO [Safinamide Mesylate^{C₁₇H₁₉FN₂O₂CH₄O₃S}]

RX

-

100mg (oral tablet)

50mg (oral tablet)

Us Worldmeds Llc^{Mar 21, 2017}

Adjunctive treatment to levodopa/carbidopa in patients with parkinson's disease experiencing 'off' episodes.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Carbidopa FDA Approved Drugs